Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Aspirin Resistance as a Result of Impaired Interaction of Platelets and Neutrophils in Patients with Coronary Heart Disease

https://doi.org/10.20996/1819-6446-2021-01-07

Full Text:

Abstract

Aim. To study the relationship between the levels of synthesis of reactive oxygen species (ROS) by platelets and neutrophils in patients with coronary heart disease (CHD) before and after coronary artery bypass grafting (CABG), depending on sensitivity to acetylsalicylic acid (ASA).

Material and methods. The study included 95 patients with coronary artery disease who are indicated for CABG surgery. The control group consisted of 30 healthy donors. The antiplatelet therapy was stopped for at least 5 days before CABG. In the postoperative period, from the first day, all patients were received 100 mg of an enteric form of acetylsalicylic acid (ASA). Resistance to ASA was determined at the level of platelet aggregation with arachidonic acid ≥20% by optical agregometry at least at one observation point: before CABG, on 1-3 day and on 8-10 day after surgery. We evaluated the spontaneous and induced lucigenin-dependent chemiluminescence (CL) of platelets (ADP induction) and neutrophils (zymosan induction) by the exit time to maximum intensity (Tmax), maximum intensity (Imax) and area (S) under the CL curve.

Results. 70.5% sensitive (sASA) and 29.5% resistant (rASA) to ASA patients were revealed. Prior to CABG, in sASA patients, the Imax of spontaneous and zymosan-induced neutrophil CL and CL platelet activity was increased relative to control values. Tmax of spontaneous platelet CL, Imax and S under the ADP-induced platelet CL curve were lower in sASA patients, if to compare with rASA patients. On the 1st and 8-10th day after CABG in sASA patients, the CL indicators of neutrophil and platelet activity also remained elevated compared to control values. On the 1st day after CABG decreased levels of S under the spontaneous CL curve of neutrophils in rASA patients was established compared with sASA patients, and increased levels of Imax and S under the curve of induced neutrophil CL were detected in comparison with the control range. In rASA patients, the values of Tmax of spontaneous platelet CL decreased in relation to the values detected in the control group and sASA patients. On the 8–10th day after CABG, most indicators of spontaneous and zymosan-induced CL neutrophils in rASA patients were also increased compared to control values. In rASA patients a positive correlation of Imax-induced CL was found (r=0.83) on the 1st day after CABG and negative correlations of Tmax of spontaneous CL (r=- 0.75) and S under the curve induced CL (r=-0.70) on the 8-10th day were detected between platelets and neutrophils.

Conclusion. In sASA patients with coronary heart disease before and after CABG, a high level of synthesis of superoxide radical by neutrophils and platelets was detected. The relationship between the levels of the synthesis of superoxide radical by neutrophils and platelets was found only after CABG in rASA patients. Increased synthesis of superoxide radical due to metabolic and regulatory relationships in neutrophils and platelets stimulates pro-inflammatory processes in coronary artery disease and determines the sensitivity of platelets to ASA.

About the Authors

M. D. Goncharov
Federal Center of Cardiovascular Surgery; Professor V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation

Maxim D. Goncharov

Красноярск

eLibrary SPIN: 2544-5109



A. A. Savchenko
Professor V. F. Voino-Yasenetsky Krasnoyarsk State Medical University; Federal Research Center «Krasnoyarsk Science Center» of the Siberian Branch of the Russian Academy of Sciences, Scientific Research Institute of medical problems of the North
Russian Federation

Andrei A. Savchenko

Красноярск

eLibrary SPIN: 3132-8260



Yu. I. Grinshtein
Professor V. F. Voino-Yasenetsky Krasnoyarsk State Medical University;Professor V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation

Yury I. Grinshtein

Красноярск

eLibrary SPIN: 1219-3804



I. I. Gvozdev
Federal Research Center «Krasnoyarsk Science Center» of the Siberian Branch of the Russian Academy of Sciences, Scientific Research Institute of medical problems of the North
Russian Federation

Ivan I. Gvozdev

Красноярск

eLibrary SPIN: 6203-4651



A. A. Kosinova
Professor V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation

Aleksandra A. Kosinova

Красноярск

eLibrary SPIN: 2108-0220



T. S. Mongush
Federal Center of Cardiovascular Surgery; Professor V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation

Tayra S. Mongush

Красноярск

eLibrary SPIN: 3095-1506



References

1. Patrono C., Bachmann F., Baigent C., et al. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. Eur Heart J. 2004;25(2):166-81. DOI:10.1016/j.ehj.2003.10.013.

2. Puchinyan N.F., Furman N.V., Kiselev A.R., Dovgalevsky Y.P. Risk of repeated thrombotic events in patients survived acute coronary syndrome and having laboratory proven resistance to acetylsalicylic acid. Rational Pharmacotherapy in Cardiology. 2009;5(6):41-6 (In Russ.) DOI:10.20996/1819-6446-2009-5-6-41-46.

3. Aynetdinova D.H., Udovichenko A.E., Sulimov V.A. Resistance to antiplatelet drugs in patients with ischemic heart disease. Rational Pharmacotherapy in Cardiology. 2007;3(3):52-9 (In Russ.) DOI:10.20996/1819-6446-2007-3-3-52-59.

4. Grinshtein Y.I., Kosinova A.A., Grinshtein I.Y. Antiplatelet therapy control: credibility gap or search for new decisions? Rational Pharmacotherapy in Cardiology. 2013;9(6):682-9 (In Russ.) DOI:10.20996/1819-6446-2013-9-6-682-689.

5. Golukhova E.Z., Ryabinina M.N. Current aspects of antiplatelet therapy. Kreativnaya Kardiologiya. 2013;1:46-57 (In Russ.)

6. Grosser T., Fries S., Lawson J.A., et al. Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin. Circulation. 2013;127(3):377-85. DOI:10.1161/CIRCULATIONAHA.112.117283.

7. Ren Q., Chan K.W., Huang H., et al. Platelet-derived alpha-granules are associated with inflammation in patients with NK/T-cell lymphoma-associated hemophagocytic syndrome. Cytokine. 2020;126:154878. DOI:10.1016/j.cyto.2019.154878.

8. Teixeira C., Fernandes C.M., Leiguez E. et al. Inflammation Induced by Platelet-Activating Viperid Snake Venoms: Perspectives on Thromboinflammation. Front Immunol. 2019;10:2082. DOI:10.3389/fimmu.2019.02082.

9. Vitkovsky Y.A., Kuznick B.I., Solpov A.V. Pathogenetic significance of lymphocyte-to-platelet adherence. Medical Immunology (Russia). 2006;8(5-6):745-53 (In Russ.) DOI:10.15789/1563-0625-2006-5-6-745-753.

10. Fuentes E., Gibbins J.M., Holbrook L.M., Palomo I. NADPH oxidase 2 (NOX2): A key target of oxidative stress-mediated platelet activation and thrombosis. Trends Cardiovasc Med. 2018;28(7):429- 34. DOI:10.1016/j.tcm.2018.03.001.

11. Ghasemzadeh M., Hosseini E., Roudsari Z.O., Zadkhak P. Intraplatelet reactive oxygen species (ROS) correlate with the shedding of adhesive receptors, microvesiculation and platelet adhesion to collagen during storage: Does endogenous ROS generation downregulate platelet adhesive function? Thromb Res. 2018;163:153-61. DOI:10.1016/j.thromres.2018.01.048.

12. Paul M., Hemshekhar M., Kemparaju K., Girish K.S. Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity. Free Radic Biol Med. 2019;130:196-205. DOI:10.1016/j.freeradbiomed.2018.10.453.

13. Pinegina N.V. Leukocyte-platelet complexes in the pathogenesis of acute coronary syndrome. Part 2. Kreativnaya Kardiologiya. 2016;10(3):201-9 (In Russ.)

14. Savchenko A.A., Zdzitovetskii D.E., Borisov A.G., Luzan N.A. Chemiluminescent and enzyme activity of neutrophils in patients with widespread purulent peritonitis depending on the outcome of disease. Annals of the Russian Academy of Medical Sciences. 2014;69(5-6):23-8 (In Russ.) DOI:10.15690/vramn.v69i5-6.1039.

15. Savchenko A.A., Kudryavtsev I.V., Borisov A.G. Methods of estimation and the role of respiratory burst in the pathogenesis of infectious and inflammatory diseases. Russian Journal of Infection and Immunity. 2017;7(4):327-40 (In Russ.) DOI:10.15789/2220-7619-2017-4-327-340.

16. Savchenko E.A., Savchenko A.A., Gerasimchuk A.N., Grishchenko D.A. Assessment of the metabolic status of platelets in normal and coronary heart disease. Russian Clinical Laboratory Diagnostics. 2006;(5);33-6. (In Russ.)

17. Grinshtein Yu.I., Filonenko I.V., Savchenko A.A., et al. A method for the diagnosis of resistance to acetylsalicylic acid. Patent 2413953, Russian Federation. Published 03/10/2009 Bull. No 7. (In Russ.)

18. Grinshtein Yu.I., Savchenko A.A., Grinshtein I.Yu., Savchenko E.A. Features of hemostasis, platelet metabolic activity and the frequency of aspirin resistance in patients with chronic heart failure after coronary artery bypass grafting. Kardiologiia. 2008;48(6);51-6 (In Russ.)

19. Finamore F., Reny J.L., Malacarne S. et al. A high glucose level is associated with decreased aspirinmediated acetylation of platelet cyclooxygenase (COX)-1 at serine 529: A pilot study. J. Proteomics. 2019;192:258-66. DOI:10.1016/j.jprot.2018.09.007.

20. Jiang X., Liu X., Liu X., et al. Low-Dose Aspirin Treatment Attenuates Male Rat Salt-Sensitive Hypertension via Platelet Cyclooxygenase 1 and Complement Cascade Pathway. J Am Heart Assoc. 2020;9(1):e013470. DOI:10.1161/JAHA.119.013470.

21. Pastori D., Pignatelli P., Carnevale R., Violi F. Nox-2 up-regulation and platelet activation: Novel insights. Prostaglandins Other Lipid Mediat. 2015;120:50-5. DOI:10.1016/j.prostaglandins.2015.03.010.

22. Qin Y.Y., Li M., Feng X., et al. Combined NADPH and the NOX inhibitor apocynin provides greater anti-inflammatory and neuroprotective effects in a mouse model of stroke. Free Radic Biol Med. 2017;104:333-45. DOI:10.1016/j.freeradbiomed.2017.01.034.

23. Lösche W., Temmler U., Redlich H., et al. Inhibition of leukocyte chemiluminescence by platelets: role of platelet-bound fibrinogen. Platelets. 2001;12(1):15-9. DOI:10.1080/09537100020031171.


For citation:


Goncharov M.D., Savchenko A.A., Grinshtein Yu.I., Gvozdev I.I., Kosinova A.A., Mongush T.S. Aspirin Resistance as a Result of Impaired Interaction of Platelets and Neutrophils in Patients with Coronary Heart Disease. Rational Pharmacotherapy in Cardiology. 2021;17(1):16-22. (In Russ.) https://doi.org/10.20996/1819-6446-2021-01-07

Views: 248


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)